Search
Now showing items 1-5 of 5
Brain-derived neurotrophic factor (BDNF) protein levels in anxiety disorders : systematic review and meta-regression analysis
(Frontiers, 2013-07)
Background: Brain-Derived Neurotrophic Factor (BDNF) is a neurotrophin that is involved in the synaptic plasticity and survival of neurons. BDNF is believed to be involved in the pathogenesis of several neuropsychiatric ...
The association between hypertension and depression and anxiety disorders : results from a nationally-representative sample of South African adults
(Public Library of Science, 2009-05-14)
Objective: Growing evidence suggests high levels of comorbidity between hypertension and mental illness but there are few data from low- and middle-income countries. We examined the association between hypertension and ...
The development of the visual screening tool for anxiety disorders and depression : addressing barriers to screening for depression and anxiety disorders in hypertension and/or diabetes
(AOSIS, 2018-06)
Background: There is a lack of screening tools for common mental disorders that can
be applied across cultures, languages and levels of education in people with diabetes and
hypertension.
Aim: To develop a visual screening ...
Big effects of small RNAs : a review of MicroRNAs in anxiety
(SpringerLink, 2012-11)
Epigenetic and regulatory elements provide an
additional layer of complexity to the heterogeneity of anxiety
disorders. MicroRNAs (miRNAs) are a class of small,
noncoding RNAs that have recently drawn interest as ...
Generalised anxiety disorder
(AOSIS, 2013)
Generalised anxiety disorder (GAD) is a common disorder witha lifetime prevalence of 6.1% and a 1-year prevalence of 2.9% inone large study.[1]It occurs most commonly in the 45 - 55-yearage group with women twice as likely ...